Biosynthetic proteins targeting the sars-cov-2 spike as anti-virals

HIGHLIGHTS

• who: Stu00e9phanie Thu00e9bault and collaborators from the (UVE), Universitu00e9, IRD, INSERM, France, UMR Virologie, INRAE-ENVAANSES, Eu0301cole Nationale Vu00e9tu00e9rinaire d`Alfort, Universitu00e9 Paris-Est, Maisons-Alfort, Paris, FranceEditor: Stanley Perlman, University of Iowa have published the research work: Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals, in the Journal: (JOURNAL) of March/16,/2022
• what: To increase avidity and neutralization activity of these RBD binders, the authors aimed at generating multivalent u03b1Reps. The authors focused on the nasal cavity as the authors choose to examine how a local treatment could limit the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.